Prognostic value of C-reactive protein levels in patients with bone neoplasms: A meta-analysis. [PDF]
PLoS ONE, 2018 The aim of this study was to conduct a meta-analysis of retrospective studies that investigated the association of preoperative C-reactive protein (CRP) levels with the overall survival (OS) of patients with bone neoplasms.A detailed literature search ...
Wenyi Li +4 more
doaj +5 more sources
Rotationplasty outcomes assessed by gait analysis following resection of lower extremity bone neoplasms [PDF]
Bone & Joint Open, 2023 Aims: The standard of surgical treatment for lower limb neoplasms had been characterized by highly interventional techniques, leading to severe kinetic impairment of the patients and incidences of phantom pain.
Panagiotis Filis +2 more
exaly +3 more sources
miRNA-128 modulates bone neoplasms cells proliferation and migration through the WNT/β-catenin and EMT signal pathways [PDF]
Journal of Orthopaedic Surgery and Research, 2021 Background Bone neoplasms present poor prognosis due to recurrence and metastasis. Although the role microRNAs (miRNAs) in inhibiting growth and metastasis of bone neoplasms has been investigated, the underlying potential molecular mechanisms mediated by
Yang Li +4 more
doaj +2 more sources
Prognostic Value of Bone Marrow Uptake Using 18F-FDG PET/CT Scans in Solid Neoplasms
Journal of Imaging, 2022 Background: Fluorine-18-fluorodeoxyglucose positron emission tomography/computerized tomography (18F-FDG PET/CT) uptake is known to increase in infective and inflammatory conditions. Systemic inflammation plays a role in oncologic prognosis. Consequently,
Francisco Tustumi +6 more
doaj +2 more sources
Combining morphological and functional imaging parameters to diagnose primary bone neoplasms in the skull base, spine and sacrum. [PDF]
Skeletal RadiolPurpose Morphological magnetic resonance (MR) and computed tomography (CT) features are used in combination with histology for diagnosis and treatment selection of primary bone neoplasms.
Miladinovic V +7 more
europepmc +4 more sources
The bone marrow stroma in hematological neoplasms—a guilty bystander
Nature Reviews Clinical Oncology, 2011 In the setting of hematological neoplasms, changes in the bone marrow (BM) stroma might arise from pressure exerted by the neoplastic clone in shaping a supportive microenvironment, or from chronic perturbation of the BM homeostasis.
Claudio Tripodo +2 more
exaly +3 more sources
Primary bone neoplasms in dogs: 90 cases
Pesquisa Veterinária Brasileira, 2012 A retrospective study of necropsy and biopsy cases of 90 primary bone tumors (89 malignant and one benign) in dogs received over a period of 22 years at the Laboratório de Patologia Veterinária, Universidade Federal de Santa Maria, was performed ...
Maria E. Trost +7 more
doaj +2 more sources
Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management [PDF]
Cancers, 2019 Bone represents a common site of metastases for several solid tumors. However, the ability of neuroendocrine neoplasms (NENs) to localize to bone has always been considered a rare and late event.
Barbara Altieri +2 more
exaly +3 more sources
Evaluating the causal effects of circulating plasma proteins on the risk of malignant neoplasms of bone and articular cartilage [PDF]
Journal of International Medical ResearchBackground Malignant neoplasms of bone and articular cartilage represent a rare group of highly invasive tumours with a poor prognosis, whose molecular mechanisms remain incompletely understood.
Yun Wang +3 more
doaj +2 more sources
Clinical characteristic–assisted surgical benefit stratification for resection of primary tumor in patients with advanced primary malignant bone neoplasms: a population-based propensity score–matched analysis [PDF]
Frontiers in Oncology, 2023 Yuexin Tong, Dongxu Zhao, Tong Yuexin
exaly +2 more sources